Bioventix

(BVXP)
Sector: Pharmaceuticals & Biotechnology
3,733.33p
-16.67p -0.44
Last updated: 11:00:26

Share information

Name Bioventix
Epic BVXP
Isin GB00B4QVDF07
Index MID300
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 3,733.33p Net gearing n/a
Market capitalisation £194.87 Debt ratio n/a
Shares in issue 5.22 Debt-to-equity ratio n/a
P/E ratio 24 Assets / equity ratio n/a
Total dividends per share 68.00p Price to book value n/a
Dividend yield 3.9 ROCE n/a
Dividend cover 1.06 EPS growth 9
Earning per share 160.63 52-week high / low 3,225.00p / 5,060.00p

Dividends

Type Ex-date Pay-date Net-dividend
1st Interim 2024-04-11 2024-04-26 68.00p
2nd Interim 2023-11-09 2023-11-24 90.00p
1st Interim 2023-04-06 2023-04-21 62.00p
Special 2022-11-03 2022-11-18 26.00p
2nd Interim 2022-11-03 2022-11-18 74.00p
1st Interim 2022-04-07 2022-04-22 52.00p
Special 2021-10-28 2021-11-12 38.00p
2nd Interim 2021-10-28 2021-11-12 62.00p
1st Interim 2021-04-08 2021-04-23 43.00p

Contact details

Company name Bioventix
Address 27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Telephone
Website http://www.bioventix.com

Directors

Director Position
Mr Peter John Harrison CEO
Mr Bruce Hiscock CFO
Mr Ian James Nicholson Chairman
Mr Nicholas (Nick) John McCooke Independent Non-Executive Director
Mr Joanne (Jo) Pisani Independent Non-Executive Director

Company financials

Assets £ (m) 2023 2022 2021
Reporting date 30/06/23 30/06/22 30/06/21
Intangible asssets and goodwill n/a n/a n/a
Investments and other non-current assets 0.61 0.61 0.61
Total non-current assets 1.19 1.3 1.45
Inventory / work in progress 0.57 0.46 0.33
Trade and other receivables 5.81 5.22 4.63
Cash and equivalents 5.72 6.13 6.49
Other current assets and asset held for resale n/a n/a n/a
Total of all assets 13.28 13.12 12.91
Liabilities £ (m) 2023 2022 2021
Short term liabilities 1.2 1.25 1.01
Long term liabilities 0.02 0.04 0.08
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 1.22 1.3 1.09
Net assets £ (m) 2023 2022 2021
Net assets 12.06 11.82 11.82
Equity £ (m) 2023 2022 2021
Share capital 0.26 0.26 0.26
Minority interests n/a n/a n/a
Retained earnings 10.33 10.23 10.23
Share premium account 1.47 1.33 1.33
Total equity 12.06 11.82 11.82
Income £ (m) 2023 2022 2021
Turnover n/a n/a n/a
Operating profit 10.03 9.27 8.09
Pre-tax profit 10.13 9.28 8.12